Morgan Stanley Maintains Underweight on Adient, Raises Price Target to $29

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and raises the price target from $27 to $29.

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and raises the price target from $27 to $29.

Total
0
Shares
Related Posts
Read More

FedNat Holding Says ‘Neither the Board nor the SRC has set a specific timetable for conclusion of the strategic review, and the Company does not intend to comment further unless and until the Board has approved a specific course of action’

Neither the Board nor the SRC has set a specific timetable for conclusion of the strategic review, and the Company does not intend to comment further unless and until the Board has approved a specific course of action or

FNHC